Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Double Blind, With Evaluator Blinding, Parallel, Randomized Clinical Trial, to Assess the Efficacy of Platelet Rich Plasma for Treatment of Muscle Rupture With Haematoma

NCT01440725 is registered in ClinicalTrials.gov with Institut de Terapia Regenerativa Tissular as lead sponsor.

NCT NCT01440725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01440725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Double Blind, With Evaluator Blinding, Parallel, Randomized Clinical Trial, to Assess the Efficacy of Platelet Rich Plasma for Treatment of Muscle Rupture With Haematoma
Lead sponsor
Institut de Terapia Regenerativa Tissular
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
December 31, 2012
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscle injuries